Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and α-interferon immunotherapy

A. Toren, A. Ackerstein, D. Gazit, R. Or, D. Raveh, U. Kupolovicz, D. Engelhard, A. Nagler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

A patient with Hodgkin's disease (HD) underwent autologous bone marrow transplantation (ABMT). Six months later while receiving interleukin (IL)-2 and α-interferon immunotherapy, he developed a painful lesion in his oral cavity with a fistula in the buccal area. Excision biopsy disclosed necrotizing granulomatous inflammation with acid-fast bacillus. The patient received a 9-month course of isoniazide, rifampin and pyranizamide, and recovered. The possible pathophysiological mechanism is discussed.

Original languageEnglish
Pages (from-to)209-210
Number of pages2
JournalBone Marrow Transplantation
Volume18
Issue number1
StatePublished - Jul 1996
Externally publishedYes

Keywords

  • Autologous bone marrow transplantation
  • Immunotherapy
  • Tuberculosis

Fingerprint

Dive into the research topics of 'Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and α-interferon immunotherapy'. Together they form a unique fingerprint.

Cite this